SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR).

From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure and a left ventricular ejection fraction (LVEF) ...

Firearm injury-related emergency department visit rates increased from 2018 to 2020, then decreased through 2023.

Altered exposures to eight factors contribute to increasing trends in ischemic heart disease (IHD) and stroke on a global scale.

Hospital and ICU admission rates within 30 days after COVID-19 infection were greater in patients with inborn errors of immunity (IEI).

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

A scientific statement has been issued by the American Heart Association regarding the management and diagnosis of Kawasaki disease.

Among health care personnel, influenza vaccination has not returned to 2019 levels, and COVID-19 vaccinations have been decreasing.

Patients with hyperglycemic crisis at type 2 diabetes diagnosis should be closely monitored for acute kidney injury and chronic kidney disease. The risk for chronic kidney disease (CKD) is higher for ...